Estrogenicity of organophosphorus and pyrethroid pesticides

Journal of Toxicology and Environmental Health - Part A

Volumn 65, Issue 19, 2002, Pages 1419-1435

  Chen, Haiyan ^a   Xiao, Jigao ^a   Hu, Gang ^a   Zhou, Jianwei ^a   Xiao, Hang ^a   Wang, Xinru ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CIPERMETHRIN; DELTAMETHRIN; DIMETHOATE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FENVALERATE; FULVESTRANT; MALATHION; MESSENGER RNA; MONOCROTOPHOS; OPUNAL; ORGANOPHOSPHATE PESTICIDE; PERMETHRIN; PHOXIM; PROTEIN PS2; PYRETHROID; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; E SCREEN ASSAY; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0037063953     PISSN: 15287394     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984100290071243     Document Type: Article

References (39)

1. Aprea, C., Sciarra, G., Sartorelli, P., Mancini, R., and Luca, V. D. 1998. Environmental and biological monitoring of exposure to mancozea, ethylenethiourea, and dimethoate during industrial formulation. J. Toxicol. Environ. Health A 53:263-281.
2. Abu-Qare, A. W., Abdel-Rahman, A., Brownie, C., Kishk, A. M., and Abou-Donia, M. B. 2001. Inhibition of cholinesterase enzymes following a single dermal dose of chlorpyrifos and methyl parathion, alone and in combination, in pregnant rats. J. Toxicol. Environ. Health A 63:173-189.
3. Berry, M., Nunez, A. M., and Chambon, P. 1989. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 86:1218-1222.
4. Blair, R. M., Fang, H., Branham, W. S., Hass, B. S., Dial, S. L., Moland, C. L., Tong, W., Shi, L., Perkins, R., and Sheehan, D. M. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol Sci. 54:138-153.
5. Carney, E. W., Hoberman, A. M., Farmer, D. R., Kapp, R. W., Jr., Nikiforov, A. I., Bernstein, M., Hurtt, M. E., Breslin, W. J., Cagen, S. Z., and Daston, G. P. 1997. Estrogen modulation: Tiered testing for human hazard evaluation. Reprod. Toxicol. 11:879-892.
6. Cole, D. C., Carpio, F., Julian, J., and Léon, N. 1998. Assessment of peripheral nerve function in an Ecuadorian rural population exposed to pesticides. J. Toxicol. Environ. Health A 55:77-91.
7. Dauvois, S., Danielian, P. S., White, R., and Parker, M. G. 1992. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA 89:4037-4041.
8. Dauvois, S., White, R., and Parker, M. G. 1993. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell. Sci. 106:1377-1388.
9. de Cupis, A., and Favoni, R. E. 1997. Oestrogen/growth factor cross-talk in breast carcinoma: A specific target for novel antioestrogens. Trends Pharmacol. Sci. 18:245-251.
10. Garey, J., and Wolff, M. S. 1998. Estrogenic and antiprogestagenic activities of pyrethroid insecticides. Biochem. Biophys. Res. Commun. 251:855-859.
11. Gillesby, B. E., and Zacharewski, T. R. 1999. pS2(TFF1) levels in human breast cancer tumor samples: correlation with clinical and histological prognostic markers. Breast Cancer Res. Treat. 56:253-265.
12. Go, V., Gray, J., Wolff, M. S., and Pogo, B. G. 1999. Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line. Environ. Health Perspect. 107:173-177.
13. Gray, L. E., Jr., Kelce, W. R., Wiese, T., Tyl, R., Gaido, K., Cook, J., Klinefelter, G., Desaulniers, D., Wilson, E., Zacharewski, T., Waller, C., Foster, P., Laskey, J., Reel, J., Giesy, J., Laws, S., McLachlan, J., Breslin, W., Cooper, R., Di Giulio, R., Johnson, R., Purdy, R., Mihaich, E., Safe, S., and Colborn, T. 1997. Endocrine screening methods workshop report: Detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod. Toxicol. 11:719-750.
14. Harnagea-Theophilus, E., Gadd, S. L., Knight-Trent, A. H., DeGeore, G. L., and Miller, M. R. 1999. Acetaminophen-induced proliferation of breast cancer cells involves estrogen receptors. Toxicol. Appl. Pharmacol. 155:273-279.
15. Jeltsch, J. M., Roberts, M., Schatz, C., Garnier, J. M., Brown, A. M., and Chambon, P. 1987. Structure of the human oestrogen-responsive gene pS2. Nucleic Acids Res. 25(15):1401-1414.
16. Jones, P. A., Baker, V. A., Irwin, A., and Earl, L. K. 1997. Modulation of MCF-7 cell proliferative response by manipulation of assay conditions. Toxicol. In Vitro 11:769-773.
17. Jorgensen, M., Vendelbo, B., Skakkebaek, N. E., and Leffers, H. 2000. Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. Environ. Health Perpect. 108:403-412.
18. Klotz, D. M., Arnold, S. F., and McLachlan, J. A. 1997. Inhibition of 17 beta-estradiol and progesterone activity in human breast and endometrial cancer cells by carbamate insecticides. Life. Sci. 60:1467-1475.
19. Lackey, R. R., Gray, S. I., and Henricks, D. M. 2001. Crosstalk and considerations in endocrine disruptor research. Med. Hypoth. 56:644-647.
20. Lowry, O. H., Rosebrough, N. L., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
21. McLachlan, A. J. 1993. Functional toxicology: A new approach to detect biologically active xenobiotics. Environ. Health Perspect. 101:386-387.
22. MacGregor, J. I., and Jordan, V. C. 1998. Basic guide to the mechanisms of antiestrogen action. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50:151-196.
23. Mellanen, P., Petanen, T., Lehtimaki, J., Makela, S., Bylund, G., Holmbom, B., Mannila, E., Oikari, A., and Santti, R. 1996. Wood-derived estrogens: Studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol. Appl. Pharmacol. 136:381-388.
24. Mileson, B. E., Chambers, J. E., Chen, W. L., Dettbarn, W., Ehrich, M., Eldefrawi, A. T., Gaylor, D. W., Hamernik, K., Hodgson, E., Karczmar, A. G., Padilla, S., Pope, C. N., Richardson, R. J., Saunders, D. R., Sheets, L. P., Sultatos, L. G., and Wallace, K. B. 1998. Common mechanism of toxicity: A case study of organophosphorus pesticides. Toxicol. Sci. 41:8-20.
25. Nunez, A. M., Berry, M., Imler, J. L., and Chambon, P. 1989. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J. 8:823-829.
26. Petit, F., Le Goff, P., Cravedi, J. P., Valotaire, Y., and Pakdel, F. 1997. Two complementary bioassays for screening the estrogenic potency of xenobiotics: Recombinant yeast for trout estrogen receptor and trout hepatocyte cultures. J. Mol. Endocrinol. 19:321-335.
27. Pope, C. N. 1999. Organophosphorus pesticides: Do they all have the same mechanism of toxicity? J. Toxicol. Environ. Health B 2:161-181.
28. Rawlings, N. C., Cook, S. J., and Waldbing, D. 1998. Effects of the pesticides carbofuran, chlorpyrifos, dimethoate, lindane, triallate, trifluralin, 2,4-D, and pentachlorophenol on the metabolic endocrine and reproductive endocrine system in ewes. J. Toxicol. Environ. Health A 54:21-36.
29. Ren, L., Marquardt, M. A., and Lech, J. J. 1997. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chem. Biol. Intract. 104:55-64.
30. Ribieras, S., Tomasetto, C., and Rio, M. C. 1998. The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim. Biophys. Acta 1378:F61-F77.
31. Rio, M. C., Bellocq, J. P., Gairard, B., Rasmussen, U. B., Krust, A., Koehl, C., Calderoli, H., Schiff, V., Renaud, R., and Chambon, P. 1987. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. USA 84:9243-9247.
32. Roy, D., Palangat, M., Chen, C. W., Thomas, R. D., Colerangle, J., Atkinson, A., and Yan, Z. J. 1997. Biological and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J. Toxicol. Environ. Health 50:1-29.
33. Saito, K., Tomigahara, Y., Ohe, N., Isobe, N., Nakasuka, I., and Kaneko, H. 2000. Lack of significant estrogenic or antiestrogenic activity of pyrethroid insecticides in three in vitro assays based on classic estrogen receptor alpha-mediated mechanisms. Toxicol. Sci. 57:54-60.
34. Sonnenschein, C., and Soto, A. M. 1998. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid. Biochem. Mol. Biol. 65:143-150.
35. Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandez, M. F., Olea, N., and Serrano, F. O. 1995. The ESCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103(S7):113-122.
36. Tonilol, P. G., Levitz, M., Zeleniuch, J. A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. 1995. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. JNCI 87:190-197.
37. Villalobos, M., Olea, N., Brotons, J. A., Olea-Serrano, M. F., Ruiz, d. A. J. M., and Pedraza, V. 1995. The E-screen assay: A comparison of different MCF7 cell stocks. Environ. Health Perspect. 103:844-850.
38. Wang, F., Porter, W., Xing, W., Archer, T. K., and Safe, S. 1997. Identification of a functional imperfect estrogen-responsive element in the 5′-promoter region of the human cathepsin D gene. Biochemistry 36:7793-7801.
39. Zacharewski, T. R., Bondy, K. L., McDonell, P., and Wu, Z. F. 1996. Antiestrogenic effect of 2, 3, 7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res. 54:2707-2713.